106 related articles for article (PubMed ID: 2681686)
1. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
Lasdun A; Reznik S; Molineaux CJ; Orlowski M
J Pharmacol Exp Ther; 1989 Nov; 251(2):439-47. PubMed ID: 2681686
[TBL] [Abstract][Full Text] [Related]
2. Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo.
Molineaux CJ; Lasdun A; Michaud C; Orlowski M
J Neurochem; 1988 Aug; 51(2):624-33. PubMed ID: 3292705
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endopeptidase 24.15 greatly increases the release of luteinizing hormone and follicle stimulating hormone in response to luteinizing hormone/releasing hormone.
Lasdun A; Orlowski M
J Pharmacol Exp Ther; 1990 Jun; 253(3):1265-71. PubMed ID: 2113581
[TBL] [Abstract][Full Text] [Related]
4. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of inhibitors incorporating beta -amino acids of metalloendopeptidase EC 3.4.24.15.
Steer DL; Lew RA; Perlmutter P; Smith AI; Aguilar MI
J Pept Sci; 2000 Sep; 6(9):470-7. PubMed ID: 11016884
[TBL] [Abstract][Full Text] [Related]
7. Endopeptidase 24.15 inhibition and opioid antinociception.
Kest B; Orlowski M; Bodnar RJ
Psychopharmacology (Berl); 1992; 106(3):408-16. PubMed ID: 1349191
[TBL] [Abstract][Full Text] [Related]
8. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
9. Peptidases that degrade gonadotropin-releasing hormone: influence on LH secretion in the ewe.
Lew RA; Cowley M; Clarke IJ; Smith AI
J Neuroendocrinol; 1997 Sep; 9(9):707-12. PubMed ID: 9355038
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts.
Lew RA; Tetaz TJ; Glucksman MJ; Roberts JL; Smith AI
J Biol Chem; 1994 Apr; 269(17):12626-32. PubMed ID: 8175672
[TBL] [Abstract][Full Text] [Related]
12. Effects of a metalloendopeptidase-24.15. Inhibitor on renal hemodynamics and function in rats.
Yang XP; Saitoh S; Scicli AG; Mascha E; Orlowski M; Carretero OA
Hypertension; 1994 Jan; 23(1 Suppl):I235-9. PubMed ID: 8282366
[TBL] [Abstract][Full Text] [Related]
13. Involvement of metallo-endopeptidase in degradation of luteinizing hormone-releasing hormone by neuronal and glial cells cultured from rat fetal brain.
Sakurada C; Ishii S; Yokosawa H
Neuropeptides; 1991 Feb; 18(2):77-82. PubMed ID: 2017301
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.
Shrimpton CN; Abbenante G; Lew RA; Smith I
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):351-6. PubMed ID: 10620512
[TBL] [Abstract][Full Text] [Related]
15. Effects of D-amino acid substituents on degradation of LHRH analogues by proximal tubule.
Flouret G; Majewski T; Peterson DR; Kenny AJ; Carone FA
Am J Physiol; 1987 Mar; 252(3 Pt 1):E320-6. PubMed ID: 3548429
[TBL] [Abstract][Full Text] [Related]
16. Norepinephrine-stimulated in vitro release of luteinizing hormone-releasing hormone (LHRH) from median eminence tissue is facilitated by inhibition of LHRH-degrading activity in hens.
Contijoch AM; Johnson AL; Advis JP
Biol Reprod; 1990 Feb; 42(2):222-30. PubMed ID: 2186814
[TBL] [Abstract][Full Text] [Related]
17. Isolation and structural characterization of chicken hypothalamic luteinizing hormone releasing hormone.
King JA; Millar RP
J Exp Zool; 1984 Dec; 232(3):419-23. PubMed ID: 6394691
[TBL] [Abstract][Full Text] [Related]
18. Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. II. Cleavage of native salmon GnRH, mammalian LHRH, and their analogs in the pituitary, kidney, and liver.
Zohar Y; Goren A; Fridkin M; Elhanati E; Koch Y
Gen Comp Endocrinol; 1990 Aug; 79(2):306-19. PubMed ID: 2202611
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus.
Schriefer JA; Molineaux CJ
J Pharmacol Exp Ther; 1993 Aug; 266(2):700-6. PubMed ID: 8394914
[TBL] [Abstract][Full Text] [Related]
20. Is the metalloendopeptidase EC 3.4.24.15 (EP24.15), the enzyme that cleaves luteinizing hormone-releasing hormone (LHRH), an activating enzyme?
Cleverly K; Wu TJ
Reproduction; 2010 Feb; 139(2):319-30. PubMed ID: 19755481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
